These PROTACs were very efficient in degrading ALK (DC50 ~ 10 nM in H3122 NSCLC cells) and inhibiting the proliferation of ALK-dependent ALCL and NSCLC cells. Here, ALK is linked to non-small cell lung carcinoma.